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APOBEC3B can impair genomic stability
by inducing base substitutions in
genomic DNA in human cells
Masanobu Shinohara, Katsuhiro Io, Keisuke Shindo, Masashi Matsui, Takashi Sakamoto, Kohei Tada,
Masayuki Kobayashi, Norimitsu Kadowaki & Akifumi Takaori-Kondo
Department of Hematology and Oncology, Graduate school of medicine, Kyoto University, Kyoto 606-8507, Japan.
Human APOBEC3 proteins play pivotal roles in intracellular defense against viral infection by catalyzing
deamination of cytidine residues, leading to base substitutions in viral DNA. Activation-induced cytidine
deaminase (AID), another member of the APOBEC family, is capable of editing immunoglobulin (Ig) and
non-Ig genes, and aberrant expression of AID leads to tumorigenesis. However, it remains unclear whether
APOBEC3 (A3) proteins affect stability of human genome. Here we demonstrate that both A3A and A3B
can induce base substitutions into human genome as AID can. A3B is highly expressed in several lymphoma
cells and somatic mutations occur in some oncogenes of the cells highly expressing A3B. Furthermore,
transfection of A3B gene into lymphoma cells induces base substitutions in cMYC gene. These data suggest
that aberrant expression of A3B can evoke genomic instability by inducing base substitutions into human
genome, which might lead to tumorigenesis in human cells.
I
t is widely recognized that the accumulation of genetic changes in tumor-related genes is essential for cancer
development1. With the innovation of high-throughput sequencing technology, genome-wide analyses on
various types of cancer cells have revealed numerous somaticmutations in tumor-related genes2. Some of these
mutations are caused by defects in DNA repair systems (e.g., DNA mismatch repair deficiencies give rise to
hereditary non-polyposis colon cancer3), whereas mechanisms that account for themajority of genetic changes in
cancer cells are poorly understood. Referring to somatic base substitution spectra in cancer cells, C/G to T/A
transitions are most prevalent, especially in gastric cancer, colorectal cancer, glioma, and melanoma2,4,5. This
strong bias in somatic mutations suggests the existence of active mechanisms that induce C/G to T/A transitions
into genomic DNA. It is obviously attributable to ultraviolet irradiation and following repair process against
pyrimidine dimer in case of melanoma, but not in others.
The humanAPOBEC family proteins can induce C to T (G to A, in complementary sequences) transitions into
target DNA through cytidine deamination. The APOBEC family is comprised of a series of molecules with
conserved cytidine deaminase domains (CDAs), including AID, APOBEC1, APOBEC2, APOBEC3A to H,
and APOBEC46,7. Among them, AID plays a crucial role in somatic hypermutation and class switch recombina-
tion of Ig genes, which enables diversification of immune system8. AID has been considered the only molecule
that can induce C/G to T/A transitions into genomic DNA. The expression of AID is highly regulated and
restricted in germinal center B-cells under physiological conditions, but with inflammatory stimulations, AID
can be overexpressed in not only B-cells but also other types of cells (e.g., epithelial cells) via activation of NF-kB9.
Aberrant expression of AID results in the accumulation of mutations in non-Ig genes10, which leads to develop-
ment of various cancers such as gastric and hepatic cancers as well as lymphomas9,11–13.
A series of seven A3 genes are tandemly arrayed on human chromosome 22, and the main function of the
resulting gene products is to protect the cells from retroviruses and endogenous mobile retroelements14,15. A3B,
A3D, A3F, and A3G contain two CDAs, instead of one in A3A, A3C, and A3H. A3G is a powerful anti-retroviral
molecule that induces cytidine deamination in viral genome and acts as a host defensive factor against viruses
such as HIV-116. A3A and A3B have been reported as potent inhibitors of retrotransposons17. Thus, A3 proteins
act as sentinels in innate immunity against mobile DNA/RNA including viruses, while little is known about the
effect of these proteins on nuclear DNA, in other words, host human genome. Recent studies have demonstrated
that A3A impairs nuclear DNA under the condition of suppressing uracil DNA-glycosylase (UNG) which
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However, it is still unclear whether A3 proteins can induce somatic
mutations into human genome with intact DNA repair systems.
Here we first demonstrate that expression of A3B and A3A as well
as AID can induce somatic mutations in genomic DNA in human
cells even in the presence of UNG. We also find that high expression
of A3B leads to somatic mutations in tumor-related genes. These
data suggest that aberrant expression of A3B might be one of the
active mechanisms that induce somatic mutations in cancer cells.
Results
A3 and AID induce hypermutations into foreign DNA. Besides
A3A, we focused on A3B because it is localized predominantly in the
nucleus20,21 and highly expressed inmany types of cancer cells14 refer-
ring tomicroarray database (e.g., NextBio: http://www.nextbio.com).
Previous studies have shown that A3B contains two enzymatically
active CDAs in restricting HIV-122, whereas only carboxyl-terminal
CDA is responsible for inhibiting HBV replication23,24 and editing
bacterial DNA22. A3B is also shown to restrict foreign DNA in mam-
malian cells25, but it has not been tested which CDA is active in this
context. First, to examine whether A3 and AID induce mutations
in foreignDNA in human cells andwhichCDA is responsible for this
DNA editing, we constructed amino- and/or carboxyl-terminal CDA
mutants (H66R, H253R, and H66/253R) by site directed mutage-
nesis (Fig. 1a) and confirmed their expression in HEK293 cells by
immunoblotting (Fig 1b). We transfected expression vectors for
these together with EGFP expression vector into HEK293 cells and
examined base substitutions in EGFP sequences. The expression
vector for UNG inhibitor (UGI) was also co-transfected to avoid
UNG-triggered degradation of uracil-containing foreign DNA as
described previously25. We recovered total DNA from the cells 2
days after transfection and performed differential DNA denatura-
tion PCR (3D-PCR) to efficiently recover edited DNA sequences26.
3D-PCR is based on the principle that DNA sequences with fewer
interstrand hydrogen bonds dissociates easier. If cytidine deamination
takes place frequently, resulting AT-rich EGFP gene can be amplified
at lower denaturation temperatures. Although PCR products were
obtained from all samples at 92uC of denaturation temperature
(Td), we obtained robust PCR products at 83.8uC of Td only from
A3A-, A3B wild-type (WT)-, and AID-expressing cells (Fig 2a).
Amplification of EGFP at the lowest Td was impaired in H66R-
expressing cells compared to A3B WT-expressing cells and undetec-
table in H253R- or H66/253R-expressing cells (Fig 2a, bottom). To
ascertain whether EGFP gene was actually hyperedited, we cloned and
sequenced the amplicons at 83.8uC of Td. As can be seen from the
mutation matrices, high levels of C/G to T/A transitions were
introduced into EGFP sequences (Fig 2b). To compare the extent of
baseline mutations and that of A3B-induced mutations, we also
cloned and sequenced the amplicons at 94.0uC of Td. Mutation
frequency of A3B-expressing cells were about 6 times higher than
that of mock-transfected cells (Supplementary Fig. S1 online). The
mutation frequency in H66R-expressing cells was approximately a
half compared to that in A3B WT-expressing cells in the amplicons
at the lowest Td (Fig 2c). These data suggest that carboxyl-terminal
CDA of A3B is mainly responsible for foreign DNA editing, but both
domains are requisite for full editing activity. It is worth noting that
AID is also capable of inducing cytidine deamination into foreign
DNA.
Human A3 proteins have preferred target dinucleotide sequences
in the substrate DNA; A3A and A3B prefer to deaminate cytosine
residues flanked by 59 thymine residue, 59-TC, whereas A3G prefers
to deaminate cytosine residues flanked by 59 cytosine residue, 59-
CC25,27–29. We analyzed the context of C/G to T/A transitions in
hyperedited EGFP sequences. We observed a strong bias toward
deamination at 59-TC dinucleotides in A3A-, A3B WT-, and
H66R-expressing cells, but not in AID-expressing cells (Fig 2d).
59-TC dinucleotide preference of A3Bwas also confirmed by sequen-
cing amplicon at 94.0uC of Td which is supposed to be unbiased
(Supplementary Fig. S1 online). These data suggest that the pref-
erence of editing sites in foreign DNA by A3s coincides with that
seen in viral DNA.
A3A and A3B can edit genomic DNA in human cells. We next
investigated whether A3 proteins induce C/G to T/A transitions into
not only foreign DNA but also nuclear DNA in human cells. We first
established a HEK293 cell line stably expressing EGFP (HEK293/
EGFP) using retrovirus vector that carries EGFP. We transfected
HEK293/EGFP cells with expression vectors for A3A, A3B WT or
mutant (H66R, H253R, or H66/253R), or AID by lipofection, and
then recovered total DNA from these cells after 7-day culture. We
performed 3D-PCR of EGFP gene and obtained amplicons from
A3A-, A3B WT-, H66R-, and AID-expressing cells at lower Td
(Fig 3a). EGFP gene was recovered at Td as low as 86.3uC from
A3B WT-expressing cells, while as low as 86.5uC from A3A-,
H66R-, and AID-expressing cells. By contrast, EGFP gene was not
amplified below Td of 87uC from cells transfected withmock, H253R
or H66/253R. We repeated this procedure consisting of transfection,
DNA extraction, and 3D-PCR three times and obtained similar
results (Fig 3b). To unambiguously confirm the presence of C/G to
T/A transitions, we cloned and sequenced amplicons obtained at the
lowest Td in A3A-, A3B WT-, H66R-, and AID-expressing cells
(Fig 3c). These analyses revealed approximately 2 to 5 C/G to T/A
transitions per EGFP sequence from each sample (Fig 3d). The
transitions were detected most frequently in A3A-expressing cells,
and deaminase activity of H66R mutant was approximately a half
Figure 1 | Expression of A3A, A3B wild-type and mutants, and AID.
(A) Schematic of expression vectors. The consensus amino acid residues
for zinc-coordinating motifs are shown. Substituted residues are shown in
white. (B) Expression of HA-tagged proteins. Expression vectors were
transfected into HEK293 cells, and cell lysates were analyzed by
immunoblotting with anti-HA antibody (top panel) and anti-ß-actin
antibody (bottom panel) for loading control.
www.nature.com/scientificreports
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compared to that of A3B WT as seen in foreign DNA assays. The
contexts of C/G to T/A transitions detected from the lowest Td
amplicons in genomic DNA editing in A3-expressing cells were
distinct from those in foreign DNA editing (Fig 3e). A preference
for 59-TC dinucleotide was not apparently observed, alternatively,
59-GC dinucleotides were preferred in all samples. However, this
bias fails to reach statistical significance (p , 0.01) in a x2 test. The
preferred target sequences of AID editing were 59-GC and 59-AC
dinucleotides as described by many prior studies27,30. Mutation
frequencies and preferred target sequence of A3B was also
analyzed by using amplicons at 94.0uC of Td. Mutation frequency
of A3B-expressing cells were about 3 times higher than that of mock-
transfected cells (Supplementary Fig. S2 online). A preference for 59-
TC dinucleotide was impaired, compared to that in foreign DNA
editing assays (Supplementary Fig. S2 online). Our results reveal that
in addition to AID, A3A and A3B can induce C/G to T/A transitions
into human nuclear DNA without repressing proofreading enzymes
(e.g., UNG). Mutation frequencies were 6 to 9 per 1000 base pairs
in A3A-, A3B WT-, and AID-expressing cells, and much less fre-
quent compared to those in foreign DNA editing. As seen with
foreign DNA editing, carboxyl-terminal CDA is mainly respon-
sible for catalytic activity but not sufficient for full editing activity.
The preference context of genomic DNA editing by A3A and A3B is
different from that of viral or foreign DNA editing.
Deep sequencing reveals hyperediting of human genomic DNA by
A3 proteins. Amplicon sequencing by next-generation sequencer
has enabled to detect extremely low levels of mutations of targeted
regions in genomic DNA. To verify more certainly that A3 proteins
edit human nuclear DNA, we performed deep sequencing of A3-
expressing cells. HEK293/EGFP cells were transfected with an
empty vector or expression vectors for A3A, A3B WT, H66/253R,
or AID by lipofection, and total DNA were extracted after 7-day
culture. We amplified a portion of EGFP gene with 443 base pair
length (from thymine 56 to cytosine 498) by conventional PCR
protocol, not by 3D-PCR, and performed amplicon sequencing
with the coverage of 1337 to 2654 reads per sample. This analysis
revealed that extremely large numbers of nucleotides were substi-
tuted over the full length of amplicons in A3A-, A3BWT-, and AID-
expressing cells, whereas very few mutations were detected in mock
andH66/253R-expressing cells (Supplementary Table 1 online). C/G
to T/A transitions were observed most frequently in A3A-expressing
cells as variation rates reach approximately 7% at the maximum,
while below 3% at most in A3B- and AID-expressing cells (Fig 4a
Figure 2 | Foreign DNA editing by A3A, A3B, and AID. (A) Agarose gel analyses of 3D-PCR products from HEK293 cells. Cells were transfected with
expression vector for A3A, A3B wild-type or mutant, or AID together with pEGFP-N3 and pEF-UGI. Total DNA was recovered 2 days after transfection,
and EGFP gene was amplified by 3D-PCR at the indicated denaturation temperatures (Td). (B) Mutation matrices of hyperedited EGFP sequences
derived from cloned amplicons at 83.8uC of Td. ‘‘n’’ indicates the number of bases sequenced. We sequenced 5 clones (2,225 base pairs in total) in each
group. (C) Frequencies of C/G to T/A transitions in hyperedited EGFP genes. C/G to T/A transitions per 1,000 sequenced base pairs are shown.
(D) Dinucleotide contexts in foreign DNA editing. The rates of indicated dinucleotide sequence at the C to T transitions are shown. Asterisks indicate
statistical significance in a x2 test (p , 0.01).
www.nature.com/scientificreports
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and Supplementary Table 1 online). Themutation frequency analysis
revealed that large numbers of C/G to T/A substitutions were
induced in A3A-, A3B-, and AID-expressing cells, whereas other
types of base substitutions were very few (Fig 4b). These results are
similar to the data obtained by 3D-PCR and clonal sequencing of A3-
and AID-expressing cells, and further demonstrated that A3A and
A3B as well as AID can induce C/G to T/A transitions into genomic
DNA in human cells with intact DNA repair systems. Dinucleotide
preference of target sequence for deamination by A3A, A3B and AID
was also analyzed, however, we did not found any preference in this
experiment (Fig. 4C), suggesting the difference between foreign
DNA editing and genomic DNA editing.
Expression of A3B and somatic mutations in lymphoma cells. Al-
though AID has been reported to play important roles in lymphoma-
genesis by inducing mutations in both Ig and non-Ig genes11,12,31–34,
AID-independent mechanisms are also suggested, because AID is
not expressed in all types of B-cell lymphomas31,35. We hypothesized
that A3 may contribute to somatic mutations in some lymphoma
cells. To examine this hypothesis, we first determined expression
levels of A3A, A3B, and AID by quantitative RT-PCR in several B-
cell lymphoma cell lines using peripheral blood lymphocytes (PBL)
as control (Fig 5a). Our analysis revealed that A3B was highly
expressed in 3 of 4 cell lines, particularly, markedly high in KIS1
cells, whereas expression of A3A transcripts was not detected in any
Figure 3 | Hypermutations in EGFP genes integrated in genomic DNA of HEK293 cells. (A) Agarose gel analyses of 3D-PCR products of EGFP genes
extracted fromHEK293/EGFP cells. Cells were transfected with expression vector for A3A, A3B wild-type or mutant, or AID. Total DNAwas recovered 7
days after transfection and EGFP genes were amplified by 3D-PCR at the indicated denaturation temperatures (Td). (B) Distributions of the lowest
denaturation temperatures for positive PCR amplification in each sample. Each circle represents independent experiment consisting of transfection, DNA
extraction, and 3D-PCR. (C)Mutationmatrices of hyperedited EGFP sequences derived from cloned PCR products at Td lower than 87uC. ‘‘n’’ indicates
the number of bases sequenced. We sequenced 25 clones (11,125 base pairs in total) in each group. (D) Frequencies of C/G to T/A transitions in
hyperedited EGFP genes. C/G to T/A transitions per 1,000 sequenced base pairs are shown. (E) Dinucleotide contexts in genomic DNA editing. The rates
of indicated dinucleotide sequence at the C to T transitions are shown. Deviations in the editing contexts do not reach statistical significance (p, 0.01) in
a x2 test.
www.nature.com/scientificreports
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lymphoma cell lines consistent with prior work suggesting myeloid
specificity25,36. AID transcripts were detected in 2 of 4 cell lines,
which is consistent with previous studies31,32,37. We also examined
expression of A3B in two lymph node samples of diffuse large B-
cell lymphoma, and found that A3B is actually expressed (supple-
mentary Fig. 3 online).
To investigate the correlation between A3B expression and fre-
quency of somatic mutations, we next performed direct sequencing
of cMYC, PAX5, and A20 genes which are exemplary genes mutated
frequently in B-cell lymphoma33,38. We compared mutation frequen-
cies of these genes in SUDHL-6 and KIS-1, because the expression of
A3B was the lowest in the former and the highest in the latter, while
AID was not expressed in either cell line. DNA sequences between
exon 1 and intron 1 of these three genes were analyzed (899 base pairs
of cMYC, 1550 base pairs of Pax5, and 1088 base pairs of A20), since
it have been reported that somatic mutations induced by cytidine
deaminases were concentrated within 2 kb downstream from tran-
scription initiation sites33,34. We found nine mutations within inves-
tigated sequences of cMYC and PAX5 in KIS-1, but not in SUDHL-6,
in which five of ninemutations detected were C/G to T/A transitions.
On the other hand, no mutation was detected within sequenced
region of A20 in either cells (Fig 5b). To analyze ongoing mutations
in the genome in individual cells, we next sequenced the same region
of cMYC sub-cloned from KIS-1 and SUDHL-6, and found several
more C to T mutations in KIS-1 cells, but not in SUDHL-6 cells
(Supplementary Fig. S4 online). We next determined expression of
these tumor-related genes by quantitative RT-PCR and found that
the transcripts of cMYC and PAX5 were highly expressed in both
SUDHL6 and KIS1 cells as compared to PBL, whereas A20 was less
transcribed in these lymphoma cells. These results suggest that high
expression of A3B resulted in accumulation of base alterations, espe-
cially C/G to T/A transitions, in actively transcribed tumor-related
genes in lymphoma cells.
To ascertain more definitely that A3B can edit tumor-related
genes in lymphoma cells, we introduced A3B into a lymphoma cell
line and analyzed somatic mutations in cMYC. SUDHL-6 cells were
transfected with expression vector for A3BWT, H66/253R, or mock
by electroporation and total DNA was extracted after 7-day culture.
With 3D-PCR analysis of cMYC, we obtained the amplicon from
only A3B WT-expressing cells at the lower Td (Fig 6a). Clonal
sequencing of amplicons at 85.9uC revealed 2 to 7 nucleotide sub-
stitutions per strand, and more than 80% of these mutations were C/
G to T/A transitions, with a preference for 59-GC dinucleotide sites
(Fig 6b and c). We also sequenced the amplicons at 94.0uC of Td and
Figure 4 | Deep sequencing of EGFP genes in genomic DNA. (A) The distributions of C/G to T/A substitutions in the EGFP sequences. Total DNA was
recovered formHEK293/EGFP cells 7 days after transfection with expression vector for A3A, A3B wild type or H66/253R or AID.We amplified a portion
of EGFP sequence from thymine 47 to cytidine 504 (top schematic) by PCR with high-fidelity polymerase and sequenced the amplicons by GS-junior
bench top system (Roche). Sequence data were analyzed with equipped software. ‘‘Coverage’’ indicates the total numbers of sequenced reads.
(B) Frequencies of base substitutions in hyperedited EGFP genes. Base substitutions were classified to 6 groups and substituted base number of each group
per 1,000 sequenced base pairs are show. (C) Dinucleotide contexts in genomic DNA editing. The rates of indicated dinucleotide sequence at the C to T
transitions are shown. Deviations in the editing contexts do not reach statistical significance (p , 0.01) in a x2 test.
www.nature.com/scientificreports
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found A3B-induced C/G to T/A transitions without 59-TC dinucleo-
tide preference (supplementary Fig. 5 online). These data dem-
onstrate that expression of A3B can induce somatic mutations into
actively transcribed tumor-related genes in lymphoma cells.
Discussion
To date, most studies onA3 proteins have focused on their abilities as
antiviral or antitransposon factors, whereas the capability of A3 pro-
teins to induce mutations into genomic DNA in host cells has been
scarcely verified. In contrast, many studies have elucidated that AID
induces somatic mutations into not only Ig genes, but also tumor-
related genes in human cells and that ubiquitous expression of AID
inmice leads to cancers of various organs as well as lymphomas, with
the accumulation of nucleotides alterations9–13. Thus, AID has been
considered as the only DNA cytosine deaminase that can induce
somatic mutations into human genome and has potential to cause
cancers or hematologic malignancies.
Suspe`ne et al. have recently reported that hyperediting of both
mitochondrial and nuclear DNAwas detected in human cells defect-
ive for UNGderived from hyper IgM syndrome patients and demon-
strated that A3A-induced mutations in nuclear DNA are detectable
under the condition of suppressing UNG in human cells19. In their
report, deamination of nuclear DNA was not observed in cells
expressing other A3 proteins or in cells expressing A3A without
UNG suppression. Furthermore, Landry et al. have reported that
expression of A3A together with UGI in mammalian cell lines
resulted in breaking of DNA and activation of DNA damage res-
ponse in a deaminase-dependent manner18. In these two reports, the
effect on genomic integrity byA3Awas dependent on the presence of
UGI. Thus, there has been no direct evidence that A3 proteins induce
mutations in genomic DNA in the cells with intact DNA repair
systems.
In this study, we demonstrate that A3A and A3B as well as AID
can induce C/G to T/A transitions into nuclear DNA without sup-
pressingUNGby two different assays, 3D-PCR and deep sequencing.
We assume that increased number of cytidine deamination catalyzed
by highly expressed A3A or A3B exceeded the processivity of DNA
repair enzymes such as UNG and resulted in leaving C/G to T/A
transitions in nuclear DNA.Mutation frequencies were considerably
lower compared to Suspe`ne’s report. However, Yoshikawa et al.
reported that AID induced hypermutations into an actively tran-
scribed gene in fibroblasts and that the mutation frequency was
approximately 4 to 6 per 1000 base pairs10, almost to the same extent
as our results. Hence the frequency of mutations induced by cytidine
deaminases into nuclear DNA is probably this extent or less in the
cells with intact DNA repair systems.
We also find thatA3B is highly expressed in several lymphoma cell
lines and that the cells expressing high levels of A3B actually pos-
sesses somatic mutations, especially C/G to T/A transitions, in act-
ively transcribed tumor-related genes. Furthermore, we reveal that
introduction of A3B into lymphoma cells induces the accumulation
of C/G to T/A transitions in cMYC gene. This is the first report that
suggests the involvement of A3B in inducing somatic mutations of
oncogenes in tumor cells. Together with the microarray database of
A3B expression in miscellaneous cancer cell lines14 (NextBio: http://
www.nextbio.com), it is possible that A3Bmay induce somaticmuta-
tions into tumor related genes in various types of cancers.
Several questions remain open. First, it remains unclear what is
preferred target sequences of A3 proteins in genomic DNA. Because
Figure 5 | Expression of A3B and somatic mutations in oncogenes in human lymphoma cell lines. (A) Quantitative RT-PCR for A3A, A3B, and AID in
lymphoma cell lines. The levels of target cDNA were normalized to the endogenous hypoxanthine phosphoribosyl transferase 1 (HPRT1) and then
compared to those in peripheral blood lymphocytes. (B)Mutational analyses ofC-myc, Pax5, andA20 in SUDH6 and KIS1 cells.We recovered total DNA
from the cells and amplified the sequence between exon1 and intron1 ofC-myc, Pax5 andA20 by PCR and performed direct sequencing of the amplicons.
Locations of somaticmutations are shown below the loci with their positions. (C) The expression levels of transcripts ofC-myc,Pax5, andA20 in KIS1 and
SUDHL6 cells. Quantitative RT-PCR was similarly performed with (a).
www.nature.com/scientificreports
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in several cancers such as breast cancer and melanoma, 59-TC is
the most prevalent target in C to T base substitutions, A3 is the
most potential candidate to induce these mutations25,28. However,
in our results, neither A3A nor A3B had a definite preference of
editing site in nuclear DNA editing, whereas a preference for 59-
TC dinucleotide was observed in foreign DNA editing as prev-
iously reported. It is possible that A3A and A3B have no distinct
favorite context in nuclear DNA editing, unlike viral and bacterial
DNA editing, because human genomic DNA is more profoundly
protected in transcription than viral or bacterial DNA and is under
survey of DNA repair systems. However, Suspene et al. reported
that target contexts of cytidine deamination in A3A1UGI-expres-
sing cells were 59-TC and 59-CC dinucleotides, which were ident-
ical to the contexts of viral or bacterial DNA editing19. We assume
that this discrepancy might be attributable to cell types or express-
ion levels in cells. Hence, further analyses should be required to
clarify the favorite target contexts of A3 proteins in nuclear DNA
editing. The second question is how transcriptional control and
post-translational modification of A3 proteins regulate A3 activity.
Because the molecules that possess a capability of editing nuclear
DNA threaten cell homeostasis, expression and activity of A3A
and A3B must be strictly controlled. AID is known to be regulated
at multiple steps39, for example, transcriptional regulation40–42, post-
transcriptional regulation by micro-RNA43,44, regulation of intracel-
lular localization45,46, and phosphorylation by PKA47,48. In contrast to
AID, little is known about how A3 proteins are regulated. It has been
reported that A3A is abundantly expressed in CD141 monocytes
and upregulated by interferon-a stimulation25,49,50. Meanwhile, it is
not clear where A3B is expressed normally25,42,49,50 and how it is
regulated. As for post-translational modification, we previously
reported that PKA-mediated phosphorylation of A3G regulates the
interaction between A3G and HIV Vif51. To better understand the
physiological roles of A3 proteins, it is important to elucidate how
their expression and activity are regulated. The last question is
whether A3 proteins can serve as an ‘‘initiator’’ of tumorigenesis.
Our results suggest A3B indeed induces somatic mutations into
genomic DNA in various human tumor cells, however, it is unclear
whether A3B proteins impair genomic DNA from the early stage of
oncogenesis. To address this question, hereafter, histopathological
and genetic analyses of transgenic mouse constitutively expressing
A3 proteins are necessary.
In conclusion, our findings provides the first evidence that A3A
and A3B can induce C/G to T/G transitions into genomic DNA
without suppressing DNA repair system. Our data also show that
high expression of A3B is related to mutation frequencies of onco-
genes in lymphoma cells. Our results suggest that A3B is an onco-
gene, like AID, which may have the capacity to evoke genomic
instability through base substitutions in human cells. Further
studies will be required to test whether endogenous A3B is capable
of impairing genomic integrity as a DNA mutator and contrib-
uting to the development of human cancers and hematologic
malignancies.
Figure 6 | A3B induced somatic mutations into c-myc gene in human lymphoma cells. (A) Agarose gel analyses of 3D-PCR products of c-Myc genes in
SUDHL6. We transfected expression vector for A3B wild-type or H66/253R or empty vector and recovered total DNA 7 days after transfection. C-myc
genes were amplified by 3D-PCR at the indicated denaturation temperatures (Td). (B) Clonal sequencing of amplicons from A3B-WT expressing
SUDHL6 cells.We sequenced 11 clones (5104 base pairs in total). Seventy six bases from thymine 310 to adenine 385 in whichmutations are concentrated
among sequenced 464 base pairs are shown. The numbers of C/G to T/A substitutions in sequenced 464 base pair length are shown at the right end.
(C) Dinucleotide contexts of somatic mutations in c-Myc gene by A3B. The rates of indicated dinucleotide sequence at the C to T transitions are shown.
Asterisks indicate statistical significance in a x2 test (p , 0.01).
www.nature.com/scientificreports
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Methods
DNA constructs and cell lines. Plasmids containing coding sequence of human A3A
and A3Bwere kindly provided by Dr. Kenzo Tokunaga21. Expression vectors for HA-
tagged A3A, A3B and AID were generated by sub-cloning of coding sequences into
pCAG-GS vector. A3B catalytic domain mutants (H66R, H253R, and H66/253R)
were generated by KOD-plus mutagenesis Kit (Toyobo). Expression vector for
Uracil-DNA glycosylase inhibitor, pEF-UGI was kindly provided by Dr. Ruben S
Harris25. HEK293 and HEK293T cells were maintained with Dulbecco’s modified
Eagle’s medium containing 10% of fetal bovine serum (FBS) and penicillin,
streptomycin, and glutamine (PSG). All B-cell lymphoma cell lines were maintained
with RPMI1640 containing 10% FBS and PSG. Retrovirus containing EGFP sequence
was produced by co-transfection of pMLV gag-pol, VSV-G, and pDON-EGFP into
HEK293T cells. HEK293/EGFP cells were generated by retroviral transduction of
EGFP and selection of 1 mg/ml G418 for two months.
Immunoblotting. HEK293 cells were transfected with expression vector for A3A,
A3B wild-type or mutant (H66R, H253R or H66/253R) or AID, and lysed with RIPA
buffer (50 mM Tris-HCl pH7.5, 150 mM NaCl, 1 mM EDTA, 1% Triton-X, 0.1%
SDS, 0.1% DOC) after 2-day culture. After centrifugation at 20,000 x g for 15 min,
supernatant wasmixed with sample buffer (Biorad), boiled for 5minutes, resolved on
12% (w/v) polyacrylamide gel, transferred to PVDF membrane (Immobilon,
Millipore), and analyzed by standard immunoblotting procedure with anti-HA
monoclonal antibody (12CA5, Roche) or anti-b-actin monoclonal antibody (AC-15,
Sigma).
3D-PCR and clonal sequencing. For foreign DNA editing assay, HEK293 cells were
transfected with pEGFP-N3, pEF-UGI, and expression vector for A3A, A3B WT or
mutant, or AID by using Fugene HD (Roche). After two-day culture, total DNA was
extracted by usingQuickGeneDNAwhole blood kit (Fuji Film). First round PCRwas
performed with primers listed in Supplementary Table S2 using rTaq DNA
polymerase (Takara), with the following reaction profile; 30 s at 94uC, 25cycles of
30 s at 94uC, 40 s at 62uC, and 90 s at 72uC followed by 10 min at 72uC. The
amplicons were separated by electrophoresis on 1% (w/v) agarose gel, and extracted
from the gel usingQiaquick Gel Extraction kit (Qiagen).We used 25 ng of first-round
PCR products as template for nested PCR using Hotstar Hifidelity DNA polymerase
(Qiagen), with the following reaction profile; 5 min at 95uC, 35 cycles of 15 s at 83–
92uC, 60 s at 62uC, 80 s at 72uC, followed by 10 min at 72uC. The amplicons derived
at 83.8uC were cloned into pT7-blue vector (Novagen). For nuclear DNA editing
assay, HEK293/EGFP cells were transfected with expression vector for A3A, A3BWT
or mutants, or AID using Fugene HD (Roche). Seven days after transfection, we
extracted total DNA from these cells with the same method of foreign DNA editing
assay. First round PCR was performed using Advantage HF2 polymerase kit
(Clontech), with the following reaction profile;1 min at 94uC, 30 cycles of 30 s at 94uC
followed by 2 min at 68uC, followed by 3 min at 68uC. We used 25 ng of first-round
PCR products for nested PCR using Hotstar Hifidelity DNA polymerase (Qiagen)
with the following reaction profile; 5 min at 95uC, 35 cycles of 15 s at 86–89uC, 60 s at
62uC, and 80 s at 72uC, followed by 10 min at 72uC. The amplicons derived at 86.5uC
and 83.8uCwere cloned into pT7-blue vector (Novagen). For c-myc gene editing assay
in lymphoma cells, we transfected SUDHL6 cells with expression vectors for A3BWT
or H66/253R by electroporation using Nucleofector (Amaxa) and extracted total
DNA from the cells 7 days after transfection. First round PCR and gel extractions of
amplicons were performed with the samemethods of nuclear DNA editing assay. We
used 25 ng of first-round PCR products for nested PCR usingHotstar Hifidelity DNA
polymerase (Qiagen), with the following reaction profile; 5 min at 95uC, 35 cycles of
15 s at 85–88uC, 60 s at 62uC, 80 s at 72uC, followed by 10 min at 72uC. The
amplicons derived at 85.3uC were cloned into pT7-blue vector (Novagen) and
sequenced using 3130xl Genetic Analyzer (Applied Biosystems).
Deep sequencing. Total DNA was extracted from HEK293/EGFP transfected with
expression vectors for A3A, A3BWTorH66/253R or AID 7 days after transfection. A
portion of EGFP gene with 443 base pair length, from thymine 56 to cytosine 498, was
amplified with the primers listed in Supplementary Table 2 using Advantage HF2
polymerase kit (Clontech), with the following reaction profile; 1 min at 94uC, 30
cycles of 30 s at 94uC followed by 2 min at 68uC, and followed by 3 min at 68uC. The
amplicons were separated by electrophoresis on 1% (w/v) agarose gel, and extracted
from the gel using Quiaquick Gel Extraction Kit (Qiagen). Purified amplicons were
sequenced usingGS junior bench top system (Roche) according to themanufacturer’s
protocol and analyzed with equipped software, GS Amplicon Variant Analyzer.
Lymphoma cell lines and patient samples. Four B-cell lymphoma cell lines
(SUDHL6, KIS1, KM-H2, and Granta519) were cultured in RPMI1640 containing
10% of fetal bovine serum (FBS) and penicillin, streptomycin, and glutamine (PSG).
We extracted total DNA from these cells by using Quick Gene DNA whole blood kit
(Fuji Film) and total RNA by using mir Vana miRNA isolation kit (Ambion). Tumor
biopsy specimens prior to treatment were obtained from two patients with diffuse
large B-cell lymphoma. The study was approved by the KyotoUniversity Institutional
Review Board and written informed consent was obtained from each patient. Total
RNAwere extracted similarly to lymphoma cell lines. Naı¨ve B-cells were isolated from
healthy donor’s peripheral blood by using MACSH naive B cell isolation kit (Miltenyi
Biotec).
Quantitative RT-PCR. Complementary DNA was synthesized from 200 ng of total
RNA using Revertra Ace qPCR RT Master Mix (Toyobo). Real-time PCR were
performed with Thunderbird SYBR qPCR Mix (Toyobo) according to
manufacturer’s protocol. Target cDNAs were normalized to the endogenous
expression level of the house keeping reference gene for hypoxanthine-guanine
phosphoribosyl transferase 1 (HPRT1) or glyceraldehyde 3-phosphate
dehydrogenase (GAPDH). All primers for real-time PCR are listed in Supplementary
Table 2.
Sequencing of oncogenes from lymphoma cell lines. We amplified portions of C-
myc, Pax5, and A20 from with the primers listed in Supplementary Table 2 using
Advantage HF2 polymerase kit (Clontech), with the following reaction profile; 1 min
at 94uC, 30 cycles of 30 s at 94uC followed by 4 min at 68uC, and followed by 3 min at
68uC. The amplicons were separated by electrophoresis on 1% (w/v) agarose gel,
extracted from the gel using Qiaquick Gel Extraction kit (Qiagen), and sequenced
using 3130xl Genetic Analyzer (Applied Biosystems). In c-Myc clonal sequencing, the
amplicon was subcloned into pTA2-vector (TOYOBO) and subsequently sequenced.
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